Helus Pharma (HELP) Stock Analysis & Price (Updated Oct 16, 2026, 4:00 PM ET)
Updated Oct 16, 2026, 4:00 PM ET
- Closed at $10.55, -4.52% vs the prior close of $11.05.
- Volume 1.31M shares, 0.8x its 50-day average.
- New SEC filings: 6-K (Oct 15, 2026).
- No new insider buys or sales reported since the prior session.
HELP slides 4.5% to $10.55. Closed at $10.55, -4.52% vs the prior close of $11.05. Day range $10.38–$11.06, opened at $11.00.
HELP daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 16, 2026 — HELP slides 4.5% to $10.55
- Closed at $10.55, -4.52% vs the prior close of $11.05. Day range $10.38–$11.06, opened at $11.00.
- Volume was 1.31M shares, 0.8x its 50-day average of 1.74M.
- Price is -13.0% vs its 50-day average ($12.12) and +39.4% vs its 200-day average ($7.57).
- 52-week range $3.76–$15.15; today's close sits at 60% of that range, 30.4% below the 52-week high.
Oct 15, 2026 — HELP jumps 6.5% to $11.05
- Closed at $11.05, +6.45% vs the prior close of $10.38. Day range $10.13–$11.15, opened at $10.30.
- Volume was 1.53M shares, 0.9x its 50-day average of 1.76M.
- Price is -8.9% vs its 50-day average ($12.13) and +46.2% vs its 200-day average ($7.56).
- 52-week range $3.76–$15.15; today's close sits at 64% of that range, 27.1% below the 52-week high.
- SEC filings that day: 6-K.
Oct 14, 2026 — HELP dips 1.1% to $10.38, a 1-month low, 3 down days in a row
- Closed at $10.38, -1.14% vs the prior close of $10.50. Day range $10.19–$10.47, opened at $10.36.
- Volume was 1.05M shares, 0.6x its 50-day average of 1.82M — lighter than usual.
- Price is -14.4% vs its 50-day average ($12.12) and +37.5% vs its 200-day average ($7.55).
- 52-week range $3.76–$15.15; today's close sits at 58% of that range, 31.5% below the 52-week high.
- That makes 3 straight losses.
Oct 13, 2026 — HELP slides 4.8% to $10.50, a 1-month low
- Closed at $10.50, -4.81% vs the prior close of $11.03. Day range $9.97–$11.31, opened at $11.31.
- Volume was 3.17M shares, 1.8x its 50-day average of 1.78M.
- Price is -13.2% vs its 50-day average ($12.10) and +39.3% vs its 200-day average ($7.54).
- 52-week range $3.76–$15.15; today's close sits at 59% of that range, 30.7% below the 52-week high.
Oct 12, 2026 — HELP slides 6.5% to $11.03
- Closed at $11.03, -6.53% vs the prior close of $11.80. Day range $10.99–$12.73, opened at $11.78.
- Volume was 2.34M shares, 1.3x its 50-day average of 1.74M.
- Price is -8.5% vs its 50-day average ($12.05) and +46.6% vs its 200-day average ($7.53).
- 52-week range $3.76–$15.15; today's close sits at 64% of that range, 27.2% below the 52-week high.
Oct 9, 2026 — HELP jumps 10.1% to $11.80
- Closed at $11.80, +10.07% vs the prior close of $10.72. Day range $10.45–$12.09, opened at $10.75.
- Volume was 1.66M shares, 1.0x its 50-day average of 1.73M.
- Price is -1.6% vs its 50-day average ($11.99) and +57.1% vs its 200-day average ($7.51).
- 52-week range $3.76–$15.15; today's close sits at 71% of that range, 22.1% below the 52-week high.
Oct 8, 2026 — HELP rises 2.0% to $10.72
- Closed at $10.72, +2.00% vs the prior close of $10.51. Day range $10.19–$10.79, opened at $10.50.
- Volume was 1.12M shares, 0.6x its 50-day average of 1.74M.
- Price is -10.0% vs its 50-day average ($11.91) and +43.2% vs its 200-day average ($7.49).
- 52-week range $3.76–$15.15; today's close sits at 61% of that range, 29.2% below the 52-week high.
- SEC filings that day: 6-K.
Oct 7, 2026 — HELP dips 2.3% to $10.51, a 1-month low, 6 down days in a row
- Closed at $10.51, -2.32% vs the prior close of $10.76. Day range $10.44–$10.81, opened at $10.63.
- Volume was 832.10K shares, 0.5x its 50-day average of 1.74M — lighter than usual.
- Price is -11.4% vs its 50-day average ($11.86) and +40.7% vs its 200-day average ($7.47).
- 52-week range $3.76–$15.15; today's close sits at 59% of that range, 30.6% below the 52-week high.
- That makes 6 straight losses.
Oct 6, 2026 — HELP slides 5.8% to $10.76, a 1-month low, 5 down days in a row
- Closed at $10.76, -5.78% vs the prior close of $11.42. Day range $10.51–$11.38, opened at $11.35.
- Volume was 1.48M shares, 0.9x its 50-day average of 1.73M.
- Price is -8.8% vs its 50-day average ($11.80) and +44.4% vs its 200-day average ($7.45).
- 52-week range $3.76–$15.15; today's close sits at 61% of that range, 29.0% below the 52-week high.
- That makes 5 straight losses.
Oct 5, 2026 — HELP dips 2.4% to $11.42, a 1-month low, 4 down days in a row
- Closed at $11.42, -2.39% vs the prior close of $11.70. Day range $11.23–$11.74, opened at $11.50.
- Volume was 1.32M shares, 0.8x its 50-day average of 1.73M.
- Price is -2.7% vs its 50-day average ($11.74) and +53.7% vs its 200-day average ($7.43).
- 52-week range $3.76–$15.15; today's close sits at 67% of that range, 24.6% below the 52-week high.
- That makes 4 straight losses.
- SEC filings that day: 6-K.
Oct 2, 2026 — HELP dips 1.8% to $11.70, a 1-month low, 3 down days in a row
- Closed at $11.70, -1.76% vs the prior close of $11.91. Day range $11.52–$12.30, opened at $12.30.
- Volume was 1.41M shares, 0.8x its 50-day average of 1.72M.
- Price is +0.3% vs its 50-day average ($11.66) and +58.0% vs its 200-day average ($7.41).
- 52-week range $3.76–$15.15; today's close sits at 70% of that range, 22.8% below the 52-week high.
- That makes 3 straight losses.
- SEC filings that day: 6-K.
HELP latest news & SEC filings
Every SEC filing by or about HELP in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Oct 15, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Oct 8, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Oct 5, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Oct 2, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Oct 1, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- So Eric H. L. received an award of 248,000 shares on Sep 30, 2026; now holds 4,713,014
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Oct 1, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Cavers Greg bought 3,000 shares at $12.91 (≈$38.73K) on Sep 29, 2026; now holds 3,000
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Oct 1, 2026 · Form 3 — New insider holdings
Initial insider ownership statement (Form 3) — a new director, officer or 10% owner disclosed their holdings
Oct 1, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Glavine Paul received an award of 248,000 shares on Sep 30, 2026; now holds 4,750,191
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Oct 1, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Sep 23, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Sep 22, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Sep 21, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Halstead Michael bought 100,000 shares at $13.47 (≈$1.35M) on Sep 21, 2026; now holds 168,568
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Sep 21, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Sep 17, 2026 · Form 3 — New insider holdings
Initial insider ownership statement (Form 3) — a new director, officer or 10% owner disclosed their holdings
Sep 10, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Things to know before you trade HELP
- How much it moves: over the last 20 sessions the average daily move was 3.72% (largest 10.4%). That is a volatile stock.
- Liquidity: about 1.54M shares (≈$16.20M) trade per day on average.
- 52-week position: $10.55 vs a range of $3.76–$15.15 (60% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 25 open-market buys, 0 sales; latest: Michael Halstead bought 100,000 shares on Sep 21, 2026.
- Latest filings: 6-K Oct 15, 2026; 6-K Oct 8, 2026; 6-K Oct 5, 2026.
- Listing: Nasdaq · industry: Pharmaceutical Preparations.
HELP market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 16, 2026 | 11.00 | 11.06 | 10.38 | 10.55 | 1.31M |
| Oct 15, 2026 | 10.30 | 11.15 | 10.13 | 11.05 | 1.53M |
| Oct 14, 2026 | 10.36 | 10.47 | 10.19 | 10.38 | 1.05M |
| Oct 13, 2026 | 11.31 | 11.31 | 9.97 | 10.50 | 3.17M |
| Oct 12, 2026 | 11.78 | 12.73 | 10.99 | 11.03 | 2.34M |
| Oct 9, 2026 | 10.75 | 12.09 | 10.45 | 11.80 | 1.66M |
| Oct 8, 2026 | 10.50 | 10.79 | 10.19 | 10.72 | 1.12M |
| Oct 7, 2026 | 10.63 | 10.81 | 10.44 | 10.51 | 832.10K |
| Oct 6, 2026 | 11.35 | 11.38 | 10.51 | 10.76 | 1.48M |
| Oct 5, 2026 | 11.50 | 11.74 | 11.23 | 11.42 | 1.32M |
| Oct 2, 2026 | 12.30 | 12.30 | 11.52 | 11.70 | 1.41M |
| Oct 1, 2026 | 12.32 | 12.48 | 11.63 | 11.91 | 1.33M |
| Sep 30, 2026 | 12.70 | 12.90 | 12.22 | 12.29 | 822.70K |
| Sep 29, 2026 | 12.60 | 12.97 | 12.44 | 12.70 | 967.30K |
| Sep 28, 2026 | 12.50 | 12.78 | 12.09 | 12.59 | 985.90K |
| Sep 25, 2026 | 12.76 | 12.86 | 12.54 | 12.61 | 805.60K |
| Sep 24, 2026 | 12.80 | 12.88 | 12.28 | 12.59 | 1.46M |
| Sep 23, 2026 | 13.60 | 13.61 | 12.81 | 13.02 | 1.85M |
| Sep 22, 2026 | 14.01 | 14.24 | 13.40 | 13.71 | 2.42M |
| Sep 21, 2026 | 12.65 | 14.05 | 12.65 | 13.66 | 2.87M |
About Helus Pharma
Helus Pharma (HELP) is listed on the Nasdaq and classified by the SEC under “Pharmaceutical Preparations”. Its business address is in TORONTO. State of incorporation: British Columbia, Canada. Fiscal year ends March 31. SEC CIK 1833141.
HELP board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Eric H. L. So | Executive Chair | Sep 11, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Paul Glavine | Chief Growth Officer | Sep 11, 2026 |
| Michael Halstead | Chief Executive Officer | Sep 21, 2026 |
| Eric H. L. So | Executive Chair | Sep 11, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Sep 21, 2026 | Michael Halstead | Buy | 100,000 | $13.47 |
| Sep 21, 2026 | Michael Halstead | Buy | 100,000 | $13.47 |
| Sep 21, 2026 | Michael Halstead | Buy | 100,000 | $13.47 |
| Sep 21, 2026 | Michael Halstead | Buy | 100,000 | $13.47 |
| Sep 8, 2026 | Paul Glavine | Buy | 100,000 | $12.47 |
| Sep 8, 2026 | Paul Glavine | Buy | 100,000 | $12.47 |
| Sep 8, 2026 | Paul Glavine | Buy | 100,000 | $12.47 |
| Sep 8, 2026 | Paul Glavine | Buy | 100,000 | $12.47 |
| Sep 8, 2026 | Paul Glavine | Buy | 100,000 | $12.47 |
| Sep 8, 2026 | Paul Glavine | Buy | 100,000 | $12.47 |
| Sep 8, 2026 | Paul Glavine | Buy | 100,000 | $12.47 |
| Sep 8, 2026 | Paul Glavine | Buy | 100,000 | $12.47 |
| Sep 8, 2026 | Eric H. L. So | Buy | 100,000 | $12.39 |
| Sep 8, 2026 | Eric H. L. So | Buy | 100,000 | $12.39 |
| Sep 8, 2026 | Eric H. L. So | Buy | 100,000 | $12.39 |
HELP financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| No annual XBRL figures available (foreign filers often report on Form 20-F). | ||||
Latest balance sheet: total assets $—, total liabilities $—, cash $—.
HELP earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| No 8-K earnings releases in recent filings. | ||
Related stocks · Pharmaceutical Preparations
Eli Lilly (LLY)Johnson & Johnson (JNJ)Merck (MRK)AbbVie (ABBV)Abbott Laboratories (ABT)Pfizer (PFE)Bristol Myers Squibb (BMY)Vertex Pharmaceuticals Inc / Ma (VRTX)Novo Nordisk A S (NVO)Regeneron Pharmaceuticals (REGN)
Popular today
Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Tesla (TSLA)Apple (AAPL)Intel (INTC)Microsoft (MSFT)Amazon (AMZN)
More on HELP
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 16, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.